Medtronic plc. Ordinary Shares (MDT): Price and Financial Metrics


Medtronic plc. Ordinary Shares (MDT)

Today's Latest Price: $112.14 USD

1.56 (-1.37%)

Updated Dec 1 7:00pm

Add MDT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

MDT Stock Summary

  • With a market capitalization of $152,837,275,176, Medtronic plc has a greater market value than 98.81% of US stocks.
  • MDT's went public 34.94 years ago, making it older than 92.92% of listed US stocks we're tracking.
  • The volatility of Medtronic plc's share price is greater than that of only 7.22% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Medtronic plc, a group of peers worth examining would be DHR, NVO, SAP, TMUS, and HON.
  • Visit MDT's SEC page to see the company's official filings. To visit the company's web site, go to www.medtronic.com.

MDT Stock Price Chart Interactive Chart >

Price chart for MDT

MDT Price/Volume Stats

Current price $112.14 52-week high $122.15
Prev. close $113.70 52-week low $72.13
Day low $111.92 Volume 5,035,459
Day high $115.13 Avg. volume 5,689,401
50-day MA $107.43 Dividend yield 2.04%
200-day MA $99.70 Market Cap 150.74B

Medtronic plc. Ordinary Shares (MDT) Company Bio


Medtronic plc manufactures and sells device-based medical therapies worldwide. The company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The company was founded in 1949 and is based in Dublin, Ireland.

MDT Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$112.14$35.76 -69%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Medtronic plc. To summarize, we found that Medtronic plc ranked in the 23th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for MDT, they are:

  • Medtronic plc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than only 24.33% of tickers in our DCF set.
  • MDT's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than only 24.33% of tickers in our DCF set.
  • As a business, Medtronic plc experienced a tax rate of about 0% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than merely 0% of stocks generating free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-69%
1%-69%
2%-69%
3%-68%
4%-68%
5%-68%

Want more companies with a valuation profile/forecast similar to that of Medtronic plc? See ABT, SKVI, CPIX, DHR, and EHC.


MDT Latest News Stream


Event/Time News Detail
Loading, please wait...

MDT Latest Social Stream


Loading social stream, please wait...

View Full MDT Social Stream

Latest MDT News From Around the Web

Below are the latest news stories about Medtronic plc that investors may wish to consider to help them evaluate MDT as an investment opportunity.

Medtronic to acquire medical device company that treats end-stage renal disease

Medtronic announced its sixth small acquisition of the year.

Star Tribune | October 2, 2020

Neuroprosthetics Market 2020: In-Depth Research On Market Size, Share, Growth Rate And Trends, 2027 | Medtronic, Inc., Neuropace, Cochlear Limited, Abbott, etc.

The recent report published by Reports and Data comprises of an in-depth assessment of the Global Neuroprosthetics Market. It assesses the ever-changing market dynamics and overall development of the industry. The report is fabricated with thorough primary and secondary research

OpenPR | October 2, 2020

Digital Patient Monitoring Devices Market Size Will Accelerate Rapidly In The Near Future With Leading Key Vendors: Medtronic Plc, Omron Corporation, ResMed, AT&T, Inc, Welch Allyn, GE Healthcare, Zephyr Technology Corporation

Patient monitoring devices in this report refer to the sensors which are used in smart wearable devices. The patient monitoring devices market is driven by increasing demand for wearable for infants and continuously evolving sensor technology. With increasing personal care

OpenPR | October 2, 2020

Global Regenerative Medicine Market Growth Analysis, Key Manufacturers and Forecast Period 2020-2026| DePuy Synthes, Medtronic, ZimmerBiomet

Regenerative Medicine Market is expected to grow significantly over next few years and generate considerable market for Regenerative Medicine. Market Report Expert has recently published a research report titled, “Regenerative Medicine Market Outlook and Statistics, 2020-2026". The report has been prepared

OpenPR | October 2, 2020

DoJ opens ventilator antitrust probe focused on Medtronic - WSJ

The U.S. Department of Justice is investigating if acquisitions by Medtronic (MDT) limited competition in ventilator manufacturing, WSJ reports, which adds that the company has received a civil subpoena from the DoJ requesting more information.The probe reportedly is centered on two acquisitions: when Covidien PLC, a device maker that sold...

Seeking Alpha | October 1, 2020

Read More 'MDT' Stories Here

MDT Price Returns

1-mo 9.48%
3-mo 6.24%
6-mo 11.25%
1-year 3.41%
3-year 47.56%
5-year 60.11%
YTD 0.68%
2019 27.34%
2018 15.18%
2017 15.90%
2016 -5.44%
2015 8.62%

MDT Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MDT Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7992 seconds.